Fatih Arslan
Fatih Arslan
Türk Dili ve Edebiyatı Bölümü Doçenti,Fırat Üniversitesi
Verified email at firat.edu.tr
Cited by
Cited by
Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury
RC Lai, F Arslan, MM Lee, NSK Sze, A Choo, TS Chen, M Salto-Tellez, ...
Stem cell research 4 (3), 214-222, 2010
F Arslan, MB Smeets, LAJ O'Neill, B Keogh, P McGuirk, L Timmers, ...
Circulation 121 (1), 80-90, 2010
Proteolytic potential of the MSC exosome proteome: implications for an exosome-mediated delivery of therapeutic proteasome
RC Lai, SS Tan, BJ Teh, SK Sze, F Arslan, DP De Kleijn, A Choo, SK Lim
International journal of proteomics 2012, 2012
Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia–reperfusion in vivo
MIFJ Oerlemans, J Liu, F Arslan, K den Ouden, BJ van Middelaar, ...
Basic research in cardiology 107 (4), 270, 2012
Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs
TS Chen, F Arslan, Y Yin, SS Tan, RC Lai, ABH Choo, J Padmanabhan, ...
Journal of translational medicine 9 (1), 1-10, 2011
The innate immune response in reperfused myocardium
L Timmers, G Pasterkamp, VC de Hoog, F Arslan, Y Appelman, ...
Cardiovascular research 94 (2), 276-283, 2012
The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction
GPJ Van Hout, L Bosch, GHJM Ellenbroek, JJ De Haan, WW Van Solinge, ...
European heart journal 38 (11), 828-836, 2017
TLR2 and TLR4 in ischemia reperfusion injury
F Arslan, B Keogh, P McGuirk, AE Parker
Mediators of inflammation 2010, 2010
Lack of fibronectin-EDA promotes survival and prevents adverse remodeling and heart function deterioration after myocardial infarction
F Arslan, MB Smeets, PW Riem Vis, JC Karper, PH Quax, LG Bongartz, ...
Circulation research 108 (5), 582-592, 2011
PCI proteins eIF3e and eIF3m define distinct translation initiation factor 3 complexes
C Zhou, F Arslan, S Wee, S Krishnan, AR Ivanov, A Oliva, J Leatherwood, ...
BMC biology 3 (1), 1-16, 2005
Derivation and characterization of human fetal MSCs: an alternative cell source for large-scale production of cardioprotective microparticles
RC Lai, F Arslan, SS Tan, B Tan, A Choo, MM Lee, TS Chen, BJ Teh, ...
Journal of molecular and cellular cardiology 48 (6), 1215-1224, 2010
Danger signals in the initiation of the inflammatory response after myocardial infarction
JJ De Haan, MB Smeets, G Pasterkamp, F Arslan
Mediators of inflammation 2013, 2013
Right ventricular dysfunction in left‐sided heart failure with preserved versus reduced ejection fraction
L Bosch, CSP Lam, L Gong, SP Chan, D Sim, D Yeo, F Jaufeerally, ...
European journal of heart failure 19 (12), 1664-1671, 2017
Intracoronary infusion of allogeneic mesenchymal precursor cells directly after experimental acute myocardial infarction reduces infarct size, abrogates adverse remodeling, and …
JH Houtgraaf, R De Jong, K Kazemi, D De Groot, TIG Van Der Spoel, ...
Circulation research 113 (2), 153-166, 2013
Treatment with OPN-305, a humanized anti–Toll-like receptor-2 antibody, reduces myocardial ischemia/reperfusion injury in pigs
F Arslan, JH Houtgraaf, B Keogh, K Kazemi, R de Jong, WJ McCormack, ...
Circulation: Cardiovascular Interventions 5 (2), 279-287, 2012
Bridging innate immunity and myocardial ischemia/reperfusion injury: the search for therapeutic targets
F Arslan, DPV de Kleijn, L Timmers, PA Doevendans, G Pasterkamp
Current pharmaceutical design 14 (12), 1205-1216, 2008
Endogenous inflammatory molecules engage Toll-like receptors in cardiovascular disease
MG Ionita, F Arslan, DPV De Kleijn, G Pasterkamp
Journal of innate immunity 2 (4), 307-315, 2010
Metabolic adaptation to a disruption in oxygen supply during myocardial ischemia and reperfusion is underpinned by temporal and quantitative changes in the cardiac proteome
X Li, F Arslan, Y Ren, SS Adav, KK Poh, V Sorokin, CN Lee, D de Kleijn, ...
Journal of proteome research 11 (4), 2331-2346, 2012
Targeting danger-associated molecular patterns after myocardial infarction
GPJ van Hout, F Arslan, G Pasterkamp, IE Hoefer
Expert opinion on therapeutic targets 20 (2), 223-239, 2016
Heterologous aggregates promote de novo prion appearance via more than one mechanism
F Arslan, JY Hong, V Kanneganti, SK Park, SW Liebman
PLoS Genet 11 (1), e1004814, 2015
The system can't perform the operation now. Try again later.
Articles 1–20